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Abstract
Recruitment, the process of accessing, screening, selecting and retaining participants for research remains a
challenge. In a randomized controlled trial, partnership-based self-management intervention for patients
who have chronic obstructive pulmonary disease (COPD) in its initial stages, and their families, a theoretical
framework developed for patients with an advanced COPD and their families was modified and
implemented in a primary care context. In contrast to recruitment to the original study where 4%
decline participation, in this study 25% of the potential patients declined participation. Although
participants were encouraged to bring a family member, only 25% of them did so. The main reason for
not being accompanied by a family member was that patients did not want anybody accompany them. Those
who had quit smoking were more often accompanied by a family member compared to those who smoked.
Reviewing the literature, the most compelling explanations for non-participation are shame and self-blame
due to smoking, and that potential participants may not have envisioned any benefits from participating
since they might not have realized that they had COPD. An alternative recruitment process needs to
embrace the situation that potential participants find themselves in and which takes account of the
issues at stake.
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Introduction
The effectiveness of healthcare intervention research
is a major issue in health sciences.1 To test the
effectiveness of such studies, a sufficient number of
participants is essential. Recruitment, the process
of accessing, screening and selecting participants
for a study, as well as retaining participants through
the research, is a challenge. Recruitment in
family intervention studies is an even greater task.1
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Family-focused interventions in the context of
chronic obstructive pulmonary disease (COPD) are
scarce,2 despite evidence of the effectiveness of
family-based interventions for individuals with
various chronic diseases and the complexity of COPD
and the impact it has on families.3,4
COPD is one of the most common chronic dis-
eases worldwide and its prevalence is on the rise.
COPD is primarily related to tobacco smoking.5 The
disease develops incrementally over many years
without people necessarily becoming aware of it.
As such, the disease may progress to an advanced
stage with irreversible health damage before the per-
son finally seeks healthcare.6 Most effort in health-
care and research has been put into developing care
for patients with advanced stages of COPD. The pro-
portion of participants who do not accept invitations
to self-management trials for people with COPD is
around 40–50%.7,8
In a randomized controlled trial (RCT), partnership
to enhance self-management for patients who have
COPD in its initial stages, and their families, a theo-
retical framework was implemented for a partnership-
based nursing practice which had been developed for
the patients’ families and the patients who have an
advanced lung disease.9 The patients were in principle
recruited into the study but were asked to have a
family member accompany them. One-quarter of
potential patients declined to participate and one-
third were excluded, giving a 41% recruitment rate.
Moreover, only 25% of those participating in the
study were accompanied by a family member. That
changed the nature of this originally family-based
RCT into a more patient-focused trial.
In this article, we attempt to understand why a
considerable proportion of people with COPD in its
early stages did not accept the invitation to participate
in a partnership-based self-management programme
for patients and family members.9 The characteristics
of that study are contrasted with its predecessor,
which was developed for patients with an advanced




The theoretical framework of partnership as practice
is the foundation for the studies. It was originally
developed for clients living with complex health
problems.12,13 Then it was adjusted to the needs of
people with advanced COPD and their families10,11
and finally for people with COPD in its initial stages
and their families.9 The partnership framework reflects
a world view that transcends the binary view of health
as the absence of disease and suggests a way to address
the meaning of health circumstances with the lung dis-
ease. Creating the meaning of the health circumstances
is regarded as a core issue to address in conjunction
with other more conventional topics, for instance, those
related to the physical and social conditions of patients.
When holistically focusing on health problems related
to the patients, predetermined goals or achievements
are not laid out beforehand other than to understand
and foster possibilities for enhancing the health expe-
rience. The Global Initiative for Chronic Obstructive
Lung Disease (GOLD) clinical guidelines are the foun-
dation for the disease treatment.5
A dialogue with participants is central in the part-
nership’s theoretical framework. The dialogue is a pro-
cess characterized by an unconditional positive regard,
trust and respect for each individual’s and family’s
values and ways of being. The dialogue is open, caring,
mutually responsive and non-directive. Events and
issues are comprehended in a context which gives them
significance – meaning. The meaning emerges or
evolves in a collaborative effort of all participants. In
the dialogue, there are three suggestive themes for
exploration: family involvement, living with symptoms
and access to healthcare, with the primary goal being
enhancement of the health experience in its entirety.
Distinctive characteristics of the studies
Comparison of the characteristics of the study of
patients with COPD in its initial stages9 and the one
with patients at an advanced stage of COPD and their
families10,11 reveals that the main differences are the
context of the studies, the seriousness of the health
condition of the patients and the research designs
(see Table 1), with consequent different emphases
in the use of the theoretical framework.
Context. The context of the study of patients with
advanced COPD was an already established outpati-
ent clinic for lung patients at a tertiary hospital.
Patients were invited to join the study when their
health situation had become serious. They started
attending the outpatient clinic, and receiving home
visits and phone calls at the same time that they were
invited to participate in the study. The patients con-
tinued receiving care after the study ended. The study
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of people with COPD in its initial stages was con-
ducted in a university research institute. The pro-
gramme had a fixed schedule and a definite ending.
Patients and families in the control group were offered
a shortened version of the self-management pro-
gramme at the end of the study.
Seriousness of COPD. The different stages of the COPD
as well as higher age of the patients with an advanced
disease required different emphases in the treatment
sessions. For instance, the way and the extent to
which living with symptoms were addressed varied
with regard to their severity, the individual recogni-
tion of their existence and their ramifications in daily
life. For people with COPD in its early stages, the
notion of bringing the progression of COPD to a halt
might have prevailed, while for the person with an
advanced disease the predominant emphasis could
have been to optimize medical treatment and the pos-
sibilities for living a meaningful life.
The component access to healthcare was addressed
differently between the studies. For a person with an
advanced disease, the most important issue might
have been to secure timely access to healthcare, while
Table 1. Characteristics of patients and recruitment for the studies of partnership-based self-management for patients
with COPD in its initial versus advanced stages and their families.
Beginning COPD (N ¼ 100a) Advanced COPD (N ¼ 50)
% (n) % (n)
Description of research
Design Randomized controlled trial Retrospective and prospective
Qualitative Qualitative
Study period 12 months 18 months
Invitation Posted letters from patients’ physician and
a phone call from the research nurse
Face-to-face by a clinical nurse specialist
Context University research institute Outpatient hospital clinic and patients’
homes
Structure 3–4 family conversations and one group
meeting over 6 months
First weekly appointments, then
indefinitely upon need
Data collection Patients and family members Patients
Patients
Stage of COPD
GOLD I and II 69 (69) 28 (14)
GOLD III and IV 31 (31) 72 (36)
Age (mean) 59 years 68 years
Gender
Women 54 (54) 78 (39)
Men 46 (46) 22 (11)
Current smokers 60 (60) 28 (14)
Knowing existence
of disease
24 (24) 100 (50)
Rejecting invitation 25 (72/291) 4 (2/52)
Exclusion 34 (100/291) 0 (0/52)
Retention 84 (100/119) 84 (42/50)
1 quit 0 quit
3 died 3 died
1 too sick 5 too sick
14 lost to follow up
Family members
Retention 60 (18/30) Not documented
12 lost to follow up
COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Chronic Obstructive Lung Disease.
aIn this study, 119 patients started participation. Characteristics of patients are presented for those 100 who finished the study. An
exception is the calculation of retention, where the number of those who started the participation was used (119 patients and 30 family
members).
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for the person with the disease in its early stages,
knowledge of and access to regular exercise and reha-
bilitation could have been of most importance.
Research designs. The research design in the study on
patients with an advanced disease was retrospective and
prospective with no control group. There was a qualita-
tive study as well.11 The inclusion criteria were GOLD
stages II–IV as diagnosed in the medical record and
repeated hospitalizations during the previous months.
The study on people with COPD in its initial stages
had the RCT design. Potential participants were
recruited from primary healthcare settings and the
offices of private lung physicians, using the following
diagnosis categories: J40-44, J96, Z71-72 and F17.
Inclusion criteria were individuals aged 45 to 65 with
mild and moderate COPD (grades II and III) as the
primary disease. In the invitation letter, it was explained
that the study was a clinical, family trial and that the
participation of a close family member was requested.
Recruitment rates
One-quarter of potential participants rejected the invi-
tation to the study on patients with COPD in its initial
stages9 compared to a negligible proportion in the
study on patients with an advanced disease.12 The
recruitment rate of family members was 25%. Family
members of patients with an advanced disease were
not participants in the study but joined patients at the
treatment sessions.
Reasons given by patients with COPD
in its early stages for not accompanying
family members in the study
Half of the patients rejecting participation did not give
a reason for the refusal (see Table 2). For those who
gave a reason, the two most common ones were being
too sick and not having time. The two most common
motives for being accompanied by a family member
were that the family member wanted to know more
about the disease and to help the patient. The main
reason given by patients for not being accompanied
by a family member was that they did not want to
have anybody with them.
Explanations for low participation of
patients and family members in the
study with patients in the early stages
of COPD
Although the recruitment rate in this intervention
study is higher than that in some previous studies,7,8
the reasons that patients with COPD had for not par-
ticipating in self-management research deserve scru-
tiny. Several possible explanations have been given,
particularly the patients’ characteristics, attitudes and
experiences, acquaintanceship with healthcare profes-
sionals, and the nature of the intervention.1
Nicotine addiction and the realization of COPD
The origins of COPD are predominately associated
with cigarette smoking. The majority of people with
COPD smoke or have smoked at some point in time.5
Addiction to nicotine means that the person’s brain
needs nicotine regularly and that he/she may smoke
more than intended, despite indications and under-
standing of detrimental effects.14 The person may not
acknowledge his/her own addiction or may minimize
the threat that smoking has on health.3 Nevertheless
the addiction dominates the person’s life since the
person does not control his/her smoking. This may
be seen by people with COPD as a failure, both as
regards not having self-control and not being able to
live up to standards in society for a healthy life.15 In
Table 2. Motives of patients to include or not to include family members in the partnership-based self-management
research for patients with COPD in its initial stages.
Includea Not includea
Help patient 27 (15) Did not want to have anybody 74 (57)
Help family member 16 (9) Did not have one 4 (3)
Know more about disease 35 (19) No one had time 21 (16)
Contribute to science 22 (12) No one willing to 1 ( 1)
Total 100 (55) Total 100 (77)
COPD: chronic obstructive pulmonary disease.
aPatients could mark more than one item.
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this study, all participants had smoked at some point
in time, and 60% were still smoking.9 Those who had
quit smoking were more often accompanied by a fam-
ily member compared with current smokers, which
might suggest that being a smoker may hinder will-
ingness to participate in self-management research.
In the study, one-quarter of the participants were
unaware that they had COPD.9 Similar findings have
been repeatedly reported elsewhere.16,17 Since the
majority of the patients were at stages of COPD which
were expected to give considerable symptoms, other
issues were likely to come into play. Difficulties in
recognizing the significance of having COPD and its
accompanying long-term consequences have been
described previously.18 A tendency has also been
reported in people with COPD, even with an
advanced stage of the disease, not to consider them-
selves as a ‘person with COPD’.19 Symptoms of
COPD, particularly breathing problems and restric-
tions in physical activity, develop gradually. There-
fore, people may slowly adjust to the symptoms
without recognizing them as indicators of COPD.6,20
Hence, people may view having COPD as ‘a way of
life’21,22 irrespective of a compromised health condi-
tion. The presence of acute symptoms, even a full-
blown exacerbation, might ultimately lead to a situation
where people with COPD are, for the first time, really
confronted with their health problem.6,20,23
Experiential aspects of patients with COPD
The experiences of people with COPD in its initial
stages are gaining increasing attention, particularly
shame and self-blame.20,23 Shame may be intensified
by self-blame – a situation which is commonly asso-
ciated with smoking24–27 – to the extent that these
people may feel they have to deal with the disease
on their own20 and even refrain from participation in
research programmes.19 Conversely, there are studies
showing that being diagnosed with COPD stimulates
patients to take actions to improve their health.18,20
Still, the influences of shame and self-blame might
hinder the process of seeking assistance for smoking
cessation as well as participating in a research pro-
gramme where smoking and its consequences are the
main focus.18,19
Families
Family members of patients with COPD have been
described as the ‘hidden client’,28 despite indications
of the impact that COPD has on families.3,4 Conversely,
support from family and friends of people may encour-
age those with COPD to live a smoke-free and healthier
life.20 The majority of the patients participating in this
study did not want to be accompanied by a family mem-
ber despite the convincing request that was made in the
invitation letter. Non-participation by family members
was quite disappointing, given the fact that studies of
self-management programmes for families living with
COPD are almost non-existent2 and family-based inter-
ventions for individuals with several chronic diseases
are effective.29
Strained communication about COPD has been
revealed in families, particularly when the disease
is in its early stages and the symptoms are largely
invisible.4,30 At this point in the disease process,
patients may struggle to hide their symptoms from
family members, while at the same time they may
make efforts to convince the family members that the
symptoms exist, for example, when unable to live up
to expectations of performing household chores.30
Addiction to nicotine may be difficult for family
members to understand. Strong personal views on
smoking may cause anger and frustration. Families
blame people with COPD for the disease and for
smoking, which leads to self-blame in the patients
themselves.27 Tension in families may last beyond
the point in time when the patient has quit smoking
and the smoking as such is no longer an issue,3 lead-
ing to limited success of family members in support-
ing each other.19
Acquaintanceship with healthcare practitioners
Recruitment may be influenced by whether poten-
tial participants are acquainted with the inviting
physician/healthcare professional, and consequently
it is subject to potential influence from that person,
as well as the expectations of the potential partici-
pants of gains and losses in such relationships.31
To maximize our professional connections, we
established collaboration with respected healthcare
institutions, and the participants received an invita-
tion letter from their lung/primary care physician.32
The extent to which that influenced participation is
not known.
Reports on disquieting experiences with health-
care professionals in the context of smoking are
numerous24,25,33 and may influence recruitment to
research. There is a tendency for healthcare profes-
sionals to blame patients and to consider them respon-
sible for their condition, to label them as smokers and
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to repeatedly remind them of the connections between
COPD and smoking even though they have stayed
away from smoking for several years.26,34
Disturbing experiences of interacting with healthcare
professionals may therefore interfere with potential
participants’ interest in participating in a self-
management research. The extent to which that
happened in this research is unknown.
Nature of the intervention
Participation in self-management programmes
requires ongoing and active engagement, time and
energy.35 The participants in the experimental group
were not only expected to be engaged in a compre-
hensive and time-consuming programme but to reveal
their strengths and weaknesses to others, particularly
in relation to current or previous smoking. In this
study, the participants were also expected to under-
stand new information and to consider an invitation to
give up smoking, if they were still smoking. There
was also an implied expectation that participants
might change their approach to and expectations of
important aspects of their daily life. An opportunity to
consider influences on the progression of COPD was
offered which was expected to motivate potential par-
ticipants. However, plausible benefits might have
looked quite different to those invited to join the
study since they might not have been aware of any
significant or potential health problems.35 The
partnership-based approach which was meant to
non-judgmentally embrace the health situation of
each participant/family may, therefore, not have come
through in the invitation to the study.
Inconvenient timing, travel costs, location and
being treated in a group are concerns that have been
documented regarding non-participation in self-
management research programmes,1,31 none of which
seemed to matter to the potential participants in this
research. In the few cases where participants indicated
that travel costs would be a hindrance, they were
offered reimbursement. The timing of appointments
was made convenient to the participants and meetings
were rescheduled as needed to adjust to individual
needs and preferences. Mobility problems and ill
health have been reported as barriers in some research
programmes.19 Ill health was in fact an explanation
which a few invited persons gave for non-participation.
Most, however, should have been able to easily move
around.
Alternatives to the recruitment
process
The non-readiness of potential participants to partici-
pate in the RCT of initial stage patients with COPD and
their families might lead one to conclude that since it
was their choice not to participate, that decision should
be respected and they should be left alone until a later
time when the disease has progressed and they have
become aware of it and its ramifications. However, the
non-readiness may have been a consequence of the
nature of the tobacco addiction to preserve “a need
of the body [to continue to smoke], and an automatic
action of the body, rather than merely an intellectual
choice” (p. 9, italics in original).3 It is likely that sev-
eral people with COPD in its initial stages do not real-
ize how serious the disease is and what may be ahead
for those having it. Consequently, we as healthcare
professionals are obliged to continue to make efforts
to reach out to them and invite them into research.
The most promising alternative recruitment pro-
cess is to have face-to-face contact with potential
participants where a respectful, trusting and welcom-
ing approach is taken in person-centred conversations,
instead of using a posted invitation letter.1 There are,
however, limited options to gain face-to-face access
to individuals and families with a member who has
COPD in its early stages. The primary reason is that
the patients may not yet be regular clients of the
healthcare system since the disease has not developed
to a stage that requires stringent medical manage-
ment. Still, recruiting participants face-to-face in reg-
ular appointments with physicians/other healthcare
professionals either in primary care centres or lung
physician offices is crucial. Under such circum-
stances, the potential participants would be seeking
healthcare for an active health problem. The situation
would be related to respiratory issues or connected to
likely co-morbidities of COPD36 for which a disease
diagnosis with spirometry needs to be made. In cases
where the person has a confirmed COPD diagnosis,
the clinician would refer the patient to a research team
that would simultaneously on-site, face-to-face, or in
a telephone conversation present the study in more
detail. Including the family in research would need
to be raised in these conversations, preferably right at
the beginning. An option might be to have one more
step in the recruitment process, that is, to invite the
family member later when the patient has become
more capable and has a deeper understanding of his/
her health circumstances.
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Conclusion
A concerted effort needs to be made to develop an
effective recruitment process of patients in self-
management studies for people with COPD in its ini-
tial stages and their families. Recruitment efforts need
to embrace the situation that potential participants
find themselves in; to recognize the nature and con-
sequences of nicotine addiction and its companions
shame and self-blame. The fact that a considerable
number of potential patients may not realize that they
have COPD also needs to be acknowledged. The con-
flict that might exist between family members that
may make patients unwilling to be accompanied by
a family member needs to be accounted for in the
recruitment process. Therefore, a stepwise recruit-
ment process might be necessary.
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4. Jónsdóttir H. Research-as-if-practice. A study of
family nursing partnership with couples experiencing
severe breathing difficulties. J Fam Nurs 2007; 13(4):
443–60.
5. Global Strategy for the Diagnosis, Management and
Prevention of COPD. Global Initiative for Chronic
Obstructive Lung Disease (GOLD). http://goldcopd.
org/global-strategy-diagnosis-management-preven
tion-copd-2016/ (2016, accessed 1 May 2017).
6. Jagana R, Bartter T and Joshi M. Delay in diagnosis
of chronic obstructive pulmonary disease: reasons
and solutions. Curr Opin Pulm Med 2015; 21(2):
121–125.
7. Bischoff EWMA, Akkermans R, Bourbeau J, et al.
Comprehensive self-management and routine monitor-
ing in chronic obstructive pulmonary disease patients
in general practice: randomised controlled trial. BMJ
2012; 345: e7642.
8. Voncken-Brewster V, Tange H, de Vries H, et al. A
randomized controlled trial evaluating the effectiveness
of a web-based, computer-tailored self-management
intervention for people with or at risk for COPD. Int J
COPD 2015; 10: 1061–1073.
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teppa?–Íslensk faraldsfræðileg rannsókn]. Icelandic
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